Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Chiu, David ^a,b   Zhou, Gang ^a,b   Qin, Dajiang ^a   Niu, Lizhi ^a,b   Cai, Jinlei ^a   He, Lihua ^a,b   Tan, Dongfeng ^c   Xu, Kecheng ^a,b  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b Fuda Cancer Hospital of Guangzhou   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD44v6; Cryosurgery; Integrin 1; mRNA; PC; Protein

Indexed keywords

BETA1 INTEGRIN; CD44V6 ANTIGEN; HERMES ANTIGEN; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CELL DIFFERENTIATION; CRYOSURGERY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; PANCREAS TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TIME; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; ANTIGENS, CD29; ANTIGENS, CD44; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CRYOSURGERY; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM STAGING; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84883183584     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-146     Document Type: Article

References (32)

1. Velanovich V, Kheibek T, Khan M. Relationships of postoperative complications from preoperative biliary stents after pancreaticoduodenectomy. A new cohort analysis, meta-analysis. JOP 2009, 25:24-29.
2. Limongelli P, Khorsandi SE. Management of delayed postoperative hemorrhage after pancreatic oduodenectomy: a meta-analysis. Arch Surg 2008, 67:1001-1007.
3. Vin Y, Sima CS, Getrajdmani GI. Management outcomes of postpancreatectomy fistula, leak, abscess results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 2008, 207:490-498. 10.1016/j.jamcollsurg.2008.05.003, 18926450.
4. Surlin V, Ramboiu S, Ghilusi M, Plesea IE. Incidental intraoperative discovery of a pancreatic neuroendocrine tumor associated with chronic pancreatitis. Diagn Pathol 2012, 7:242-243.
5. Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ. Pronostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 2008, 247:490-500. 10.1097/SLA.0b013e31815b9cae, 18376195.
6. Li Y, Guo Z, Wang HT, Liu F, Ni H. Clinical study of cryoablation in the salvage treatment of stage III non-small cell lung cancer. Zhonghua Yi Xue Za Zhi 2011, 91:2205-2207.
7. Xu KC, Niu LZ, He WB. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol 2003, 59:2686-2689.
8. Xu KC, Niu LZ, He WB. Sequential treatment of transarterial chemoembolization percutaneous cryoablation for unresectable primary liver cancer. World J Gastroenterol 2003, 9:2688-2689.
9. Yoshikane Y, Yotaro I, Masafumi K, Seishi N, Hideki Y, Norimasa T. Percutaneous Cryoablation of Pulmonary Metastases from Colorectal Cancer. Plos One 2011, 6:2707-2710.
10. Xu KC, Niu LZ, Hu YZ. A pilot study on combination of cryoablation and 125iodine seed implantation for treatment of locally advanced PC. World J Gastroenterol 2008, 14:1603-1611. 10.3748/wjg.14.1603, 2693760, 18330956.
11. Eble JA, Haier J. CD44 in cancer treatment. Curr Cancer Drug Targets 2006, 6:89-105. 10.2174/156800906776056518, 16529540.
12. Hinton CV, Avraham S, Avraham HK, Vchera JU, Tucths JI. Contributions of integrin-linked kinase to breast cancer metastasis and tumour igenesis. Cell Mol Med 2008, 12:1517-1526.
13. Diaz LK, Zhou X, Wright ET, Reight ER. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 2005, 11:3309-3314. 10.1158/1078-0432.CCR-04-2184, 15867228.
14. Lin Y, Buckha PJ, Lee JR. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. Neoplasia 2009, 11:864-873. 2735797, 19724680.
15. Miyoshi T, Konda K, Hino H, Therti H, Ruifg R. The expression of the CD44 variant exon6 is associated with lymph node metastasis in non-small cell lung cancer. Clin Cancer Res 1997, 3:1289-1297.
16. Yang GY, Xu KS. integrin α-β6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 2008, 99:879-887. 10.1111/j.1349-7006.2008.00762.x, 18294287.
17. Yao ES, Zhang H, Chen YY. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007, 67:659-664. 10.1158/0008-5472.CAN-06-2768, 17234776.
18. Gansauge F, Rau B, Scheiblich A, Poch B, Schoenberg MH. Low plasma levels of soluble CD44v6 are significantly associated with poor prognosis in patients with pancreatic carcinoma. Cancer 1997, 80:1733-1739. 10.1002/(SICI)1097-0142(19971101)80:9<1733::AID-CNCR6>3.0.CO;2-F, 9351541.
19. Katz MH, Hwang R, Fleming JB, Evans DB. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 2008, 58:111-125. 10.3322/CA.2007.0012, 18272835.
20. Zhou G, Chiu D, Qin DJ, Liu LZ, Cai JL, He LH, Huang WH, Xu KC. Detection and Clinical Significance of CD44v6 and Integrin-β1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay. Appl Biochem Biotechnol 2012, 30:125-127.
21. Miller R, Siegmund D. Maximally selected chi-square statistics. Biometrics 1982, 38:1011-1016.
22. Halpern J. Maximally selected chi-square statistics for small samples. Biometrics 1982, 38:1017-1023.
23. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S. Telomerase RNA as a detection marker in the serum of breast cancer patients. Cancer Res 2000, 6:3823-3826.
24. Enders KO, Tsui NB, Lam NY, Chiu RW, Yu S, Wong SC. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002, 48:1212-1217.
25. Skubitz AP. Adhesion molecules. Cancer Treat Res 2002, 107:305-319.
26. Saito H, Tsujitani S. Plasma concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer 1998, 83:1094-1098. 10.1002/(SICI)1097-0142(19980915)83:6<1094::AID-CNCR7>3.0.CO;2-8, 9740073.
27. Ju L, Zhou C, Li W. Effect of integrin β1 up-regulation on the migration and adhesion capacity of lung cancer cell. Progress in Modern Biomedicine 2009, 9:3807-3812.
28. Zhang Y. The relation between CD44 and tumor development. J chinese medical 2005, 22:343-346.
29. Okusaka T, Funakoshi A, Furuse J, Boku N, Yamao K, Ohkawa S. A late phase II study of S1 for metastatic PC. Cancer Chemother Pharmacol 2007, 87:578-579.
30. Yamazaki H, Nishiyama K, Koizumi M, Tanaka E, Loka T. Chemoradiotherapy for adcanced PC gemcitabine can be administered using limited-field radiotherapy. Strahlenther Onkol 2007, 183:301-306. 10.1007/s00066-007-1641-1, 17520183.
31. Kovach SJ, Hendrickson RJ, Cappadona CR. Cryoablation of unresectable PC. Surgery 2002, 131:463-465. 10.1067/msy.2002.121231, 11935137.
32. Baust JG, Gage AA, Clarke D. Cryosurgery-a putative approach to molecular-based optimization. Cryobiology 2004, 48:190-194. 10.1016/j.cryobiol.2004.01.005, 15094094.